Skip to main content
    H

    HUTCHMED DRC (HCM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $14.73
    -0.17 (-1.14%)

    Market Cap: $2.59B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    HUTCHMED DRC (HCM) Financials: Revenue, Profit and Cash Flow

    Updated Jul 2, 2026. Financial statements from company filings, amounts in US dollars.

    HUTCHMED DRC reported revenue of $549.96M for the fiscal year ended Dec 31, 2025, down 12.7% from the year before. That year, net income was $458.12M with a net margin of 83.3%, operating cash flow was -$64.66M and free cash flow was -$88.81M. The quarter ended Jun 30, 2026 had revenue of $139.14M and net income of $7.96M.

    Revenue and Margins

    The operating margin was -10.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $216.08M, a compound annual rate of 10.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$549.96M-12.7%38.7%-10.0%83.3%
    Dec 2024$630.20M-24.8%44.8%-6.9%6.0%
    Dec 2023$838.00M+96.5%54.1%2.2%12.0%
    Dec 2022$426.41M+19.7%27.0%-168.6%-84.6%
    Dec 2021$356.13M+55.9%91.9%-100.3%-54.7%
    Dec 2020$228.37M+11.5%17.3%-87.0%-55.2%
    Dec 2019$204.89M-4.3%21.8%-74.6%-51.7%
    Dec 2018$214.11M-11.2%32.8%-43.3%-34.9%
    Dec 2017$241.20M+11.6%27.1%-22.1%-11.1%
    Dec 2016$216.08MN/A27.7%-21.6%5.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 1114.2% from the year before. In the quarter ended Jun 2026, net income fell 96.5% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$549.96M$630.20M$838.00M$426.41M$356.13M$228.37M$204.89M$214.11M$241.20M$216.08M
    Cost of revenue$337.24M$347.63M$384.45M$311.10M$28.79M$188.84M$160.15M$143.94M$175.82M$156.33M
    Gross profit$212.72M$282.57M$453.55M$115.31M$327.34M$39.52M$44.74M$70.17M$65.38M$59.75M
    Research and development$164.15M$213.37M$303.06M$386.89M$299.09M$176.69M$91.94M$115.58M$75.78M$66.87M
    Operating income-$54.73M-$43.70M$18.38M-$718.80M-$357.10M-$198.62M-$152.78M-$92.64M-$53.42M-$46.70M
    Net income$458.12M$37.73M$100.78M-$360.83M-$194.65M-$125.95M-$106.02M-$74.81M-$26.74M$11.70M
    EBITDA-$41.42M-$31.36M$26.58M-$351.35M-$147.34M-$192.56M-$135.13M-$82.06M-$49.50M-$43.36M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$139.14M$139.14M$135.42M$135.42M$138.84M$138.84M$162.26M$162.26M$152.84M$152.84M$152.56M$80.25M
    Gross profit$23.67M$23.67M-$23.12M-$23.12M$55.05M$55.05M-$28.17M-$28.17M$62.77M$62.77M-$86.50M-$86.50M
    Operating income$434.50K$434.50K-$17.82M-$17.82M-$1.76M-$1.76M-$8.09M-$8.09M-$13.76M-$13.76M-$46.64M-$46.64M
    Net income$7.96M$7.96M$977.50K$977.50K$227.48M$227.48M$5.96M$5.96M$12.90M$12.90M-$33.89M-$33.89M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $96.04M exceeded cash and equivalents by $24.71M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.75B$1.27B$1.28B$1.03B$1.37B$724.12M$465.12M$532.12M$597.93M$342.44M
    Current assets$1.57B$1.07B$1.10B$839.89M$1.21B$530.74M$317.02M$370.54M$432.19M$167.38M
    Cash and equivalents$71.33M$153.96M$283.59M$313.28M$377.54M$235.63M$121.16M$86.04M$85.27M$79.43M
    Total liabilities$501.84M$502.34M$536.39M$392.57M$333.15M$205.17M$152.22M$119.86M$112.97M$138.38M
    Short-term debt$27.85M$26.30M$35.08M$3.71M$31.82M$5.97M$3.58M$432.00K$31.99M$22.19M
    Long-term debt$68.19M$59.43M$48.19M$18.10M$0$26.86M$26.82M$26.74M$0$26.83M
    Shareholder equity$1.24B$759.93M$730.54M$610.37M$986.89M$484.12M$288.01M$389.00M$461.73M$184.27M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$1.74B$1.74B$1.75B$1.75B$1.78B$1.78B$1.27B$1.27B$1.26B$1.26B$1.28B$1.28B
    Total liabilities$461.46M$461.46M$501.83M$501.83M$534.02M$534.02M$502.34M$502.34M$508.85M$508.85M$536.39M$536.39M
    Cash and equivalents$106.56M$106.56M$71.33M$71.33M$110.72M$110.72M$153.96M$153.96M$203.95M$203.95M$283.59M$283.59M
    Shareholder equity$1.26B$1.26B$1.24B$1.24B$1.23B$1.23B$759.93M$759.93M$740.08M$740.08M$730.54M$730.54M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$64.66M$497.00K$219.26M-$268.60M-$204.22M-$62.07M-$80.91M-$32.85M-$8.94M-$9.57M
    Capital expenditures$24.15M$17.93M$32.61M$36.66M$16.76M$19.58M$8.56M$6.36M$5.02M$4.33M
    Free cash flow-$88.81M-$17.44M$186.65M-$305.26M-$220.98M-$81.65M-$89.48M-$39.21M-$13.96M-$13.90M
    Dividends paidN/AN/A$123.41M$87.44M$99.74M$35.00K$28.14M$24.90M$55.59M$11.66M
    Investing cash flow-$29.41M-$96.06M-$291.14M$296.59M-$306.32M-$125.44M$119.03M$43.75M-$260.78M-$33.60M
    Financing cash flow$7.84M-$30.67M$48.66M-$82.76M$650.03M$296.43M-$1.49M-$8.23M$273.20M$92.44M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$6.11M$6.11M$4.12M$4.12M-$36.45M-$36.45M$20.16M$20.16M-$19.92M-$19.92M-$3.57M-$3.57M
    Capital expenditures$2.81M$2.81M$2.44M$2.44M$4.63M$4.63M$3.91M$3.91M$5.05M$5.05M$4.13M$4.13M
    Free cash flow$3.30M$3.30M$1.68M$1.68M-$41.08M-$41.08M$16.25M$16.25M-$24.97M-$24.97M-$7.70M-$7.70M
    Last 12 quarters

    Frequently Asked Questions About HCM

    What is HUTCHMED DRC's annual revenue?

    HUTCHMED DRC reported revenue of $549.96M for the fiscal year ended Dec 31, 2025.

    How fast is HUTCHMED DRC's revenue growing?

    Revenue was down 12.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.9%.

    Is HUTCHMED DRC profitable?

    Yes. HUTCHMED DRC reported net income of $458.12M for the fiscal year ended Dec 31, 2025, with a net margin of 83.3%.

    How much free cash flow does HCM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$64.66M minus capital expenditures of $24.15M produced free cash flow of -$88.81M.

    How much debt does HUTCHMED DRC have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $68.19M, short-term debt of $27.85M and cash and equivalents of $71.33M.